Immunocore Holdings plc Common Stock, Capital Shares Reserved for Future Issuance
Immunocore Holdings plc (IMCR) had Common Stock, Capital Shares Reserved for Future Issuance of 6.17 million shares as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-02-25
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 6.17M shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 5.78M shares.
- 2023-12-31: Common Stock, Capital Shares Reserved for Future Issuance 4.17M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2025-12-31 | 6.17M shares 10-K · filed 2026-02-25 |
| 2024-12-31 | 5.78M shares 10-K · filed 2025-02-26 |
| 2023-12-31 | 4.17M shares 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |